Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 279, pseudogene (RNU6-279P)
- Target
- RNU6-279P
- Molecular classification
- Other (Pseudogene), Non-coding RNA-derived pseudogene
01
Overview
RNU6-279P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene. U6 snRNA itself is a highly conserved non-coding RNA that forms a crucial part of the spliceosome complex responsible for intron splicing in eukaryotic cells[1][3][7]. Pseudogenes like RNU6-279P result from reverse transcription and retrotransposition processes (often involving LINE/L1 elements) that copy snRNA sequences into the genome; these copies are generally non-functional and do not contribute directly to cellular biology or disease mechanisms[5][7]. RNU6-279P, like other snRNA-derived pseudogenes, does not produce a protein or functional RNA and is not targeted by any drugs or considered relevant for therapeutic intervention[4][7].
- Other names
- RNU6-279PRNA, U6 small nuclear 279, pseudogene
02
Biological functions
Other (No known function; pseudogenes are copies of functional genes that typically do not express functional products in most cases)
03
Disease associations
Other (No established roles in disease; pseudogenes, particularly those derived from small nuclear RNAs, are not generally implicated in human diseases)
Beyond the preview
Go deeper on RNA, U6 small nuclear 279, pseudogene (RNU6-279P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 279, pseudogene (RNU6-279P).